Home
Information About...
ADHD
Ageing and Mental Health
Allergies/Auto-Immune Disorders
Antisocial Behaviour
Anxiety
Autistic Spectrum Disorders
Bipolar
Depression
Dyslexia
Dyspraxia
Nutrition
Schizophrenia
Pregnancy/Infant Feeding
Sleep
Vision
Information For...
About Us
Support
Resources
Bookstore
News
Events
Links
Home -> Information About... -> Bipolar -> Virmani & Binienda 2004 - Role of carnitine esters in brain neuropathology

Role of carnitine esters in brain neuropathology

Virmani A, Binienda Z. (2004) Mol Aspects Med. 25(5-6) 533-49.
Web URL: Licensed users can view the full text of this paper here
Abstract: 

L-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl-L-carnitine (ALC) poses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.


<- Bent et al 2009 - Omega-3 Fatty Acids for Autistic Spectrum Disorder: A Systematic Review. 20 March 2009 - FAB CONFERENCE - BRIGHTON - Diet, Behaviour and The Junk Food Generation ->

Please enter your email address below and then click the blue button.

To read pdf documents on this site you may need to download Adobe Acrobat Reader. Get it here.

Website Glossary  If you hover your mouse over words that appear underlined with a blue, dashed line, a definition of that word will appear as a 'tooltip'. You may find further information about the term in our Glossary Section.

Important Notice Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.